Non Muscle Invasive and Metastatic Bladder Cancer (NMIBC) Market Assessment on Competition 2025 : TARIS BioMedical, Inc., Laurantis Pharma Oy
Non-muscle invasive and metastatic bladder cancer is an epithelial tumor, which is characterized by a high rate of dissemination.
View full press release